Clinical Trial Update: Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating imetelstat in younger patients with recurrent or refractory brain tumors was terminated, with results posted in July 2018. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Ependymoma

Drugs mentioned

• Imetelstat (imetelstat)

Snippet

Sponsor: Pediatric Brain Tumor Consortium | Conditions: Anaplastic Astrocytoma, Anaplastic Ependymoma | Phase 2 | Status: TERMINATED | Results posted: 2018-07-20